In contrast to the other family members, the current evidence suggests that HER4 mediates antiproliferative effects; and consistent with this, HER4 overactivity does not appear to play a major role in cancer pathogenesis (Sartor et al, 2001; Naresh et al, 2006). Here, ERBB4 is linked to cancer.